Interim Results of the Dropless Pars Plana Vitrectomy Study

Related

• 

  Prophylactic Ranibizumab for Exudative AMD in Vulnerable Eyes With Nonexudative AMD Trial (PREVENT) A Prospective Controlled Clinical Trial

  Maziar Lalezary, MD, FASRS

  Annual Meeting Talks

  2018

• 

  1-Year Results of a Phase 2 Pharmacodynamic Study: Subretinal Delivery of Investigational Gene Therapy ABBV-RGX-314 for Neovascular AMD

  Robert L. Avery, MD

  Updates from the Field

  2025

• 

  Failure of Macular Hole Surgery

  Abel Ramírez-Estudillo, MD

  Mauricio Bayram-Suverza, MD

  Retina Image Bank: Images of the Week

  2024